EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Production and Characterization of Self-Assembled Virus-like Particles Comprising Capsid Proteins from Genotypes 3 and 4 Hepatitis E Virus (HEV) and Rabbit HEV Expressed in Escherichia coli

Tominari Kobayashi, Masaharu Takahashi iD, Satoshi Ohta iD, Yu Hoshino, Kentaro Yamada iD, Suljid Jirintai, Putu Prathiwi Primadharsini iD, Shigeo Nagashima iD, Kazumoto Murata iD, Hiroaki Okamoto iD

Viruses · 2024

DOI: 10.3390/v16091400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Tominari Kobayashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Shimotsuke 329-0498, Tochigi, Japan. Hauptthemen laut MEDLINE: Hepatitis E virus, Escherichia coli, Genotype, Capsid Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Research Program on Hepatitis from the Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The zoonotic transmission of hepatitis E virus (HEV) genotypes 3 (HEV-3) and 4 (HEV-4), and rabbit HEV (HEV-3ra) has been documented. Vaccination against HEV infection depends on the capsid (open reading frame 2, ORF2) protein, which is highly immunogenic and elicits effective virus-neutralizing antibodies. Escherichia coli (E. coli) is utilized as an effective system for producing HEV-like particles (VLPs). However, research on the production of ORF2 proteins from these HEV genotypes in E. coli to form VLPs has been modest. In this study, we constructed 21 recombinant plasmids expressing various N-terminally and C-terminally truncated HEV ORF2 proteins for HEV-3, HEV-3ra, and HEV-4 in E. coli. We successfully obtained nine HEV-3, two HEV-3ra, and ten HEV-4 ORF2 proteins, which were primarily localized in inclusion bodies. These proteins were solubilized in 4 M urea, filtered, and subjected to gel filtration. Results revealed that six HEV-3, one HEV-3ra, and two HEV-4 truncated proteins could assemble into VLPs. The purified VLPs displayed molecular weights ranging from 27.1 to 63.4 kDa and demonstrated high purity (74.7–95.3%), as assessed by bioanalyzer, with yields of 13.9–89.6 mg per 100 mL of TB medium. Immunoelectron microscopy confirmed the origin of these VLPs from HEV ORF2. Antigenicity testing indicated that these VLPs possess characteristic HEV antigenicity. Evaluation of immunogenicity in Balb/cAJcl mice revealed robust anti-HEV IgG responses, highlighting the potential of these VLPs as immunogens. These findings suggest that the generated HEV VLPs of different genotypes could serve as valuable tools for HEV research and vaccine development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis E virusEscherichia coliGenotypeCapsid ProteinsHepatitis EVaccines, Virus-Like ParticleAnimalsRabbitsMiceMice, Inbred BALB CViral Hepatitis VaccinesFemaleHepatitis AntibodiesAntibodies, NeutralizingHumansAntibodies, ViralViral Proteins

Stichwörter der Autor:innen

Escherichia coliassembly in vitrocapsid proteingenotypehepatitis E virusvirus-like particle

Substanzen

Capsid ProteinsVaccines, Virus-Like ParticleORF2 protein, Hepatitis E virusViral Hepatitis VaccinesHepatitis AntibodiesAntibodies, NeutralizingAntibodies, ViralViral Proteins

Autor:innen und Institutionen

  • Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Shimotsuke 329-0498, Tochigi, Japan.
  • Division of Structural Biochemistry, Department of Biochemistry, Jichi Medical University School of Medicine, Shimotsuke 329-0498, Tochigi, Japan.

ORCID-Profile: Masaharu Takahashi, Satoshi Ohta, Kentaro Yamada, Putu Prathiwi Primadharsini, Shigeo Nagashima, Kazumoto Murata, Hiroaki Okamoto

Förderung

  • Japan Agency for Medical Research and Development
  • Research Program on Hepatitis from the Japan Agency for Medical Research and Development

Zitieren

APA

Kobayashi, T., Takahashi, M., Ohta, S., Hoshino, Y., Yamada, K., Jirintai, S., Primadharsini, P. P., Nagashima, S., Murata, K., & Okamoto, H. (2024). Production and Characterization of Self-Assembled Virus-like Particles Comprising Capsid Proteins from Genotypes 3 and 4 Hepatitis E Virus (HEV) and Rabbit HEV Expressed in Escherichia coli. Viruses. https://doi.org/10.3390/v16091400

Vancouver

Kobayashi T, Takahashi M, Ohta S, Hoshino Y, Yamada K, Jirintai S, et al. Production and Characterization of Self-Assembled Virus-like Particles Comprising Capsid Proteins from Genotypes 3 and 4 Hepatitis E Virus (HEV) and Rabbit HEV Expressed in Escherichia coli. Viruses. 2024. doi:10.3390/v16091400

BibTeX
@article{Kobayashi2024,
  author = {Kobayashi, Tominari and Takahashi, Masaharu and Ohta, Satoshi and Hoshino, Yu and Yamada, Kentaro and Jirintai, Suljid and Primadharsini, Putu Prathiwi and Nagashima, Shigeo and Murata, Kazumoto and Okamoto, Hiroaki},
  title = {Production and Characterization of Self-Assembled Virus-like Particles Comprising Capsid Proteins from Genotypes 3 and 4 Hepatitis E Virus (HEV) and Rabbit HEV Expressed in Escherichia coli},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16091400}
}
Kostenlos starten →